ArticleProceedings of the National Academy of Sciences of the United States of America2016

Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy.

Suzan M Hammond et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.